Financials
- Market Capitalization 8.79 B
- Employee 315
- Founded 2018
- CEO N/A
- Website www.immunovant.com
- Headquarter Delaware, United States
- FIGI BBG00P5MC0Q8
- Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-8.97
Fiyat/satışlar oranı
—
Related tickers
| # | Ad | Fiyat | 24s % | 7g % | 1A % | 1Y % | Piyasa Değeri | Son 7 Gün | |
|---|---|---|---|---|---|---|---|---|---|
| 943 | PTGX Protagonist Therapeutics, Inc. - Common Stock | 146.29 USD | -2.15% | -3.66% | +6.86% | +94.72% | 9.47 B USD | ||
| 981 | PCVX Vaxcyte, Inc. - Common Stock | 60.25 USD | -1.49% | -5.06% | +10.55% | +42.43% | 8.97 B USD | ||
| 992 | CRNX Crinetics Pharmaceuticals, Inc. - Common Stock | 84.86 USD | +0.01% | +0.15% | +1.16% | +106.47% | 9.00 B USD | ||
| 993 | ABVX Abivax SA - American Depositary Shares | 114.55 USD | +0.22% | -4.34% | -8.29% | +39.70% | 9.00 B USD |